Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 216.25 million compared to CNY 183.14 million a year ago. Revenue was CNY 216.25 million compared to CNY 183.14 million a year ago.

Net income was CNY 77.21 million compared to CNY 70.48 million a year ago. Basic earnings per share from continuing operations was CNY 0.1475 compared to CNY 0.1346 a year ago. Diluted earnings per share from continuing operations was CNY 0.1475 compared to CNY 0.1346 a year ago.